Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 2 boards, counting each seat separately. Longest: Rezolute Inc., 2 years.
Rezolute Inc.
Director
Xeris Biopharma Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +33,582 | — | — |
| Nov 19, 2025 | Rezolute Inc. | Grant or award | +21,000 | — | — |
| Jun 13, 2025 | Rezolute Inc. | Open-market purchase | +3,076 | $3.25 | $9,997 |
| Jun 10, 2025 | Rezolute Inc. | Grant or award | +9,000 | — | — |
| Feb 16, 2025 | Rezolute Inc. | Grant or award | +25,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.